7-Bromo-1-isopropyl-4,4,6-trimethyl-3 4-dihydro-1H-quinolin-2-one | 298185-52-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 7-Bromo-1-isopropyl-4,4,6-trimethyl-3 4-dihydro-1H-quinolin-2-one
• 英文别名: 7-Bromo-1-isopropyl-4,4,6-trimethyl-3,4-dihydro-1H-quinolin-2-one；7-bromo-4,4,6-trimethyl-1-propan-2-yl-3H-quinolin-2-one
• CAS: 298185-52-1
• 化学式: C₁₅H₂₀BrNO
• 分子量: 310.234
• InChiKey: UODCBMPAVVLWGY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  7-Bromo-1-isopropyl-4,4,6-trimethyl-3 4-dihydro-1H-quinolin-2-one 在 四(三苯基膦)钯 N,N-二甲基丙烯基脲 、 正丁基锂 、 potassium carbonate 作用下， 以 四氢呋喃 、 乙醇 、 甲苯 为溶剂， 生成
  参考文献：
  名称：

  RXR–LXR heterodimer modulators for the potential treatment of dyslipidemia

  摘要：

  A number of RXR agonists were synthesized and screened in functional assays. The synthesis and tile structure-activity relationship (SAR) within the series of compounds will be presented. Some in vivo data in rodent models for dyslipidemia and diabetes will also be presented. (c) 2007 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2007.01.047
• 作为产物：
  描述：

  4,4,6-三甲基-3,4-二氢-2-喹啉酮 在 氢氧化钾 、 N-溴代丁二酰亚胺(NBS) 作用下， 以 二氯甲烷 、 二甲基亚砜 为溶剂， 反应 24.0h， 生成 7-Bromo-1-isopropyl-4,4,6-trimethyl-3 4-dihydro-1H-quinolin-2-one
  参考文献：
  名称：

  RXR–LXR heterodimer modulators for the potential treatment of dyslipidemia

  摘要：

  A number of RXR agonists were synthesized and screened in functional assays. The synthesis and tile structure-activity relationship (SAR) within the series of compounds will be presented. Some in vivo data in rodent models for dyslipidemia and diabetes will also be presented. (c) 2007 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2007.01.047

文献信息

• DIHYDRO-[1H]-QUINOLIN-2-ONE DERIVATIVES AS RXR AGONISTS FOR THE TREATMENT OF DYSLIPIDEMIA, HYPERCHOLESTEROLEMIA AND DIABETES
  申请人：Lagu Bharat

  公开号：US20070078160A1

  公开（公告）日：2007-04-05

  The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating RXR mediated disorders. More particularly, the compounds of the present invention are RXR agonists useful for treating RXR mediated disorders.

  本发明涉及式（I）的化合物，制备这些化合物的方法，组合物，中间体和衍生物，以及治疗RXR介导的疾病。更具体地说，本发明的化合物是RXR激动剂，可用于治疗RXR介导的疾病。
• Amines substituted with a tetrahydroquinolinyl group an aryl or
  申请人：Allergan Sales, Inc.

  公开号：US06127382A1

  公开（公告）日：2000-10-03

  Compound of Formula 1 ##STR1## where the symbols have the meaning described in the specification, have retinoid-like biological activity.

  化学式为##STR1##的化合物，其中符号的含义在说明书中描述，具有类似维甲酸的生物活性。
• Heterocyclic amide derivatives for the treatment of diabetes and other diseases
  申请人：——

  公开号：US20030216432A1

  公开（公告）日：2003-11-20

  The present invention relates to certain substituted heterocycles of Formula (200), 1 wherein B, H, I, J and K together with the Ar 5 form a ring containing at least one amide residue, and W, X, Y and Z together form a 2,4-thiazolidinedione, 2-thioxo-thiazolidine-4-one, 2,4-imidazolidinedione or 2-thioxo-imidazolidine-4-one residue; or a pharmaceutically acceptable salt thereof. The compounds are useful in the treatment of diseases such as type 2 diabetes, and related disorders of lipid and carbohydrate metabolism, including atherosclerosis. The compounds are also useful for treating diseases of uncontrolled proliferation, such as cancers in general, including breast cancer.

  本发明涉及公式（200）的某些取代杂环，其中B、H、I、J和K与Ar5一起形成一个环，其中至少含有一个酰胺残基，W、X、Y和Z共同形成2,4-噻唑烷二酮、2-硫代噻唑烷-4-酮、2,4-咪唑烷二酮或2-硫代咪唑烷-4-酮残基；或其药学上可接受的盐。该化合物在治疗2型糖尿病、与脂质和碳水化合物代谢有关的相关疾病，包括动脉粥样硬化方面具有用处。该化合物也可用于治疗未受控制的增殖性疾病，如一般的癌症，包括乳腺癌。
• TETRAHYDROQUINOLINE DERIVATIVES HAVING RETINOID-LIKE BIOLOGICAL ACTIVITY
  申请人：Allergan Sales, Inc.

  公开号：EP1228042A2

  公开（公告）日：2002-08-07
• EP1487443A4
  申请人：——

  公开号：EP1487443A4

  公开（公告）日：2006-04-12